GlycA, a marker of acute phase glycoproteins, and the risk of incident type 2 diabetes mellitus: PREVEND study

2015102 citationsJournal Articlehybrid Open Access

Authors

Margery A. Connelly

Eke G. Gruppen · University Medical Center Groningen

Justyna Wolak-Dinsmore

Steven P. Matyus

Ineke J. Riphagen · University of Groningen

Irina Shalaurova

Stephan J. L. Bakker · University Medical Center Groningen

James D. Otvos

Robin P.F. Dullaart · University Medical Center Groningen

Abstract

The performance characteristics of the GlycA test reveal that it is suitable for clinical applications, including assessment of the risk of future T2DM.

Topics & Keywords

Adipokines, Inflammation, and Metabolic Diseases Diabetes, Cardiovascular Risks, and Lipoproteins Sepsis Diagnosis and Treatment

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: Clinica Chimica Acta

Volume 452, pp. 10-17

DOI: 10.1016/j.cca.2015.11.001

Field-Weighted Citation Impact: 8.07